Alexandra J. Lansky

1 month ago | ahajournals.org | Alexandra J. Lansky |Michael J. Schonning |William O'Neill |Juan Granada

Information & AuthorsPublished In Journal of the American Heart AssociationHistoryReceived: 1 May 2024Accepted: 30 January 2025Published online: 15 May 2025PermissionsRequest permissions for this article. Keywordsblood pressure controlhigh‐risk percutaneous coronary interventionmean arterial pressurePROTECT IIItemporary left ventricular assist device supportSubjectsDisclosuresA. J. Lansky received speaker fees from Keystone Heart. B.

2 months ago | scai.confex.com | Alexandra J. Lansky |Suzanne J. Baron |Dean Kereiakes |Frank F. Ing

Welcome to the 2025 Scientific Sessions... please wait while the program loads. Oops! Your browser seems to have javascript disabled. Make sure javascript is enabled or try opening a different browser.

May 5, 2024 | jacc.org | Alexandra J. Lansky |Daniel Grubman |Michael Dwyer |Robert Zivadinov

References1. "The problem with asymptomatic cerebral embolic complications in vascular procedures: what if they are not asymptomatic?"J Am Coll Cardiol . 2012;60:17: 1614-1616. 2. "Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis". Eur Heart J . 2019;40:38: 3143-3153. 3. "STS-ACC TVT registry of transcatheter aortic valve replacement". J Am Coll Cardiol . 2020;76:21: 2492-2516. 4.

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.

Apr 24, 2024 | citoday.com | Amit N Vora |Yousif Ahmad |Alexandra J. Lansky

Stroke is one of the most feared complications after transcatheter aortic valve replacement (TAVR) and is associated with significant morbidity, mortality, and substantial economic impact. Contemporary clinically significant stroke rates range from 2% to 4%. However, the incidence of stroke often belies the true degree of neurologic injury, with most patients demonstrating perfusion abnormality after TAVR.